U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Monday. Shares of Hyatt Hotels Corporation H ...

The article " 3 Biopharmaceutical Stocks Bucking the Sell-Off " first appeared on MarketBeat.

New option listings for April 9th include Alumis Inc , LEVERAGE SHARES 2X LONG ASML DAILY ETF (ASMG), Arrivent Biopharma Inc , REX BITCOIN CORPORATE TREASURY CONVERTIBLE BOND (BMA ...

KalVista has licenced the commercialisation rights for sebetralstat, a hereditary angioedema (HAE) treatment, to Kaken in ...

Shares of KalVista Pharmaceuticals (NASDAQ:KALV) spiked in the premarket on Tuesday after the company disclosed a licensing ...

Alumis Inc. focuses on TYK2 inhibitors ESK-001 and A-005, with ESK-001 in Phase 3 for plaque psoriasis. Find out why ALMS ...